T1	CHEM 76 86	ticagrelor
#1	AnnotatorNotes T1	C1999375; ticagrelor; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T2	ANAT 104 114	endotelial
#2	AnnotatorNotes T2	C0014257; Endothelium; Tissue
T3	ANAT 178 187	coronario
#3	AnnotatorNotes T3	C0205042; Coronary artery; Body Part, Organ, or Organ Component | C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T4	ANAT 324 333	coronario
#4	AnnotatorNotes T4	C0205042; Coronary artery; Body Part, Organ, or Organ Component | C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T5	DISO 352 357	STEMI
#5	AnnotatorNotes T5	C1536220; ST segment elevation myocardial infarction; Disease or Syndrome
T6	PROC 395 406	Tratamiento
#6	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	PROC 445 473	terapia dual antiplaquetaria
#7	AnnotatorNotes T7	C5197905; Dual Anti-Platelet Therapy; Therapeutic or Preventive Procedure
T8	CHEM 490 498	aspirina
#8	AnnotatorNotes T8	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T9	CHEM 534 557	inhibidor oral de P2Y12
T10	CHEM 571 581	ticagrelor
#9	AnnotatorNotes T10	C1999375; ticagrelor; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T11	CHEM 583 594	clopidogrel
#10	AnnotatorNotes T11	C0070166; clopidogrel; Organic Chemical · Pharmacologic Substance
T12	CHEM 597 606	prasugrel
#11	AnnotatorNotes T12	C1620287; prasugrel; Organic Chemical · Pharmacologic Substance
T13	DISO 658 680	episodios hemorrágicos
T14	PROC 783 807	consentimiento informado
#12	AnnotatorNotes T14	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T15	CHEM 906 946	inhibidores de la glicoproteína IIb/IIIa
T16	DISO 1445 1457	intolerancia
#13	AnnotatorNotes T16	C0277585; Intolerance to drug; Pathologic Function
T17	PROC 973 986	cirugía mayor
#14	AnnotatorNotes T17	C0679637; major surgery; Therapeutic or Preventive Procedure
T18	PROC 1012 1035	intervención quirúrgica
#15	AnnotatorNotes T18	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T19	DISO 1051 1059	sangrado
#16	AnnotatorNotes T19	C0019080; Hemorrhage; Pathologic Function
T20	DISO 1069 1077	sangrado
#17	AnnotatorNotes T20	C0019080; Hemorrhage; Pathologic Function
T21	DISO 1087 1092	ictus
#18	AnnotatorNotes T21	C0038454; Cerebrovascular accident; Disease or Syndrome
T22	DISO 1144 1159	trombocitopenia
#19	AnnotatorNotes T22	C0040034; Thrombocytopenia; Disease or Syndrome
T23	ANAT 1169 1178	plaquetas
#20	AnnotatorNotes T23	C0005821; Blood Platelets; Cell
T24	PROC 1186 1208	terapia anticoagulante
#21	AnnotatorNotes T24	C0150457; Anticoagulant therapy; Therapeutic or Preventive Procedure
T25	CHEM 1194 1208	anticoagulante
#22	AnnotatorNotes T25	C0003280; Anticoagulants; Pharmacologic Substance
T26	DISO 1225 1235	vasculitis
#23	AnnotatorNotes T26	C0042384; Vasculitis; Disease or Syndrome
T27	DISO 1249 1272	enfermedad inmunólógica
T28	DISO 1289 1309	fallo hepático agudo
#24	AnnotatorNotes T28	C0162557; Liver Failure, Acute; Disease or Syndrome
T29	DISO 1314 1326	hipertensión
#25	AnnotatorNotes T29	C0020538; Hypertensive disease; Disease or Syndrome
T30	CHEM 1430 1440	medicación
#26	AnnotatorNotes T30	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T31	CHEM 1470 1478	aspirina
#27	AnnotatorNotes T31	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T32	CHEM 1484 1495	clopidogrel
#28	AnnotatorNotes T32	C0070166; clopidogrel; Organic Chemical · Pharmacologic Substance
T33	CHEM 1498 1507	prasugrel
#29	AnnotatorNotes T33	C1620287; prasugrel; Organic Chemical · Pharmacologic Substance
T34	CHEM 1510 1520	ticagrelor
#30	AnnotatorNotes T34	C1999375; ticagrelor; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T35	DISO 1559 1569	neoplasias
#31	AnnotatorNotes T35	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C1882062; Neoplastic disease; Neoplastic Process
T36	PROC 1610 1634	consentimiento informado
#32	AnnotatorNotes T36	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T37	DISO 169 193	Sindrome coronario agudo
#33	AnnotatorNotes T37	C0948089; Acute Coronary Syndrome; Disease or Syndrome
T38	DISO 315 339	sindrome coronario agudo
#34	AnnotatorNotes T38	C0948089; Acute Coronary Syndrome; Disease or Syndrome
T39	PROC 611 635	régimen de mantenimiento
#35	AnnotatorNotes T39	C0814469; treatment and maintenance; Therapeutic or Preventive Procedure
T40	DISO 724 747	recurrencias isquémicas
T41	PROC 868 882	Administración
#36	AnnotatorNotes T41	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T42	CHEM 886 900	fibrinolíticos
#37	AnnotatorNotes T42	C0016018; Fibrinolytic Agents; Pharmacologic Substance
T43	ANAT 1295 1303	hepático
#38	AnnotatorNotes T43	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T44	PROC 1342 1381	presión arterial sistólica o diastólica
T45	DISO 360 366	NSTEMI
#39	AnnotatorNotes T45	C1536222; Non STEMI; Disease or Syndrome
T46	Date 13 17	2014
T48	LIVB 223 250	Pacientes hombres o mujeres
#40	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group + C0025266; Male population group; Population Group + C0043210; Woman; Population Group
T50	Age 254 270	al menos 18 años
T51	LIVB 284 293	Pacientes
#41	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	Duration 368 390	al menos 30 días antes
T53	Duration 424 440	al menos 30 días
T54	Dose 511 520	75-160 mg
T55	Frequency 521 528	diarios
T56	Route 544 548	oral
#42	AnnotatorNotes T56	C1527415; Oral Route of Drug administration; Functional Concept
T57	Neg_cue 649 657	Libre de
T58	LIVB 752 761	Pacientes
#43	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T60	Duration 950 969	los 30 días previos
T61	Duration 990 1009	los 30 días previos
T62	Duration 1121 1140	los últimos 6 meses
T63	Route 1209 1213	oral
#44	AnnotatorNotes T63	C1527415; Oral Route of Drug administration; Functional Concept
T67	Neg_cue 1582 1598	incapacidad para
T68	PHYS 1638 1646	Embarazo
#45	AnnotatorNotes T68	C0032961; Pregnancy; Organism Function
T69	PHYS 1648 1657	lactancia
#46	AnnotatorNotes T69	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T71	PHYS 1674 1682	embarazo
#47	AnnotatorNotes T71	C0032961; Pregnancy; Organism Function
T72	PHYS 96 114	función endotelial
T47	Date 407 415	en curso
A1	Assertion T13 Negated
A2	Assertion T36 Negated
A4	Assertion T40 Negated
A3	Status T38 History_of
A5	Status T5 History_of
A6	Status T45 History_of
A7	Status T41 History_of
A8	Status T42 History_of
A9	Status T15 History_of
A10	Status T17 History_of
A11	Status T20 History_of
A12	Status T21 History_of
A13	Status T16 History_of
A14	Status T27 History_of
#48	AnnotatorNotes T13	C2674164; Hemorrhagic episodes; Finding
#49	AnnotatorNotes T27	C0021053; Immune System Diseases; Disease or Syndrome
#50	AnnotatorNotes T44	C1306620; Systolic blood pressure measurement; Diagnostic Procedure + C1305849; Diastolic blood pressure measurement; Diagnostic Procedure
T49	Quantifier_or_Qualifier 1330 1340	controlada
A15	Assertion T49 Negated
T59	Neg_cue 1327 1329	no
R1	Location_of Arg1:T2 Arg2:T72	
R2	Location_of Arg1:T3 Arg2:T37	
R3	Has_Age Arg1:T48 Arg2:T50	
R4	Experiences Arg1:T51 Arg2:T38	
R5	Location_of Arg1:T4 Arg2:T38	
R6	Experiences Arg1:T51 Arg2:T5	
R7	Experiences Arg1:T51 Arg2:T45	
R8	Overlap Arg1:T45 Arg2:T52	
R9	Overlap Arg1:T5 Arg2:T52	
R10	Overlap Arg1:T38 Arg2:T52	
R13	Used_for Arg1:T8 Arg2:T7	
R12	Used_for Arg1:T8 Arg2:T6	
R14	Overlap Arg1:T8 Arg2:T47	
R11	Combined_with Arg1:T8 Arg2:T9	
R15	Has_Route_or_Mode Arg1:T9 Arg2:T56	
R16	Has_Dose_or_Strength Arg1:T8 Arg2:T54	
R17	Has_Frequency Arg1:T8 Arg2:T55	
R18	Has_Duration_or_Interval Arg1:T9 Arg2:T53	
R19	Has_Duration_or_Interval Arg1:T8 Arg2:T53	
R20	Overlap Arg1:T9 Arg2:T47	
R21	Combined_with Arg1:T8 Arg2:T10	
R22	Combined_with Arg1:T8 Arg2:T11	
R23	Combined_with Arg1:T8 Arg2:T12	
R24	Has_Duration_or_Interval Arg1:T10 Arg2:T53	
R25	Has_Duration_or_Interval Arg1:T11 Arg2:T53	
R26	Has_Duration_or_Interval Arg1:T12 Arg2:T53	
R27	Overlap Arg1:T10 Arg2:T47	
R28	Overlap Arg1:T11 Arg2:T47	
R29	Overlap Arg1:T12 Arg2:T47	
R30	Has_Duration_or_Interval Arg1:T39 Arg2:T53	
R31	Overlap Arg1:T39 Arg2:T47	
R32	Negation Arg1:T57 Arg2:T13	
T64	CONC 699 703	BARC
#51	AnnotatorNotes T64	['Bleeding Classification System Definitions']
T65	Result_or_Value 704 718	tipo 2 o mayor
R33	Has_Result_or_Value Arg1:T64 Arg2:T65	
R34	Negation Arg1:T57 Arg2:T40	
T66	Observation 813 837	participar en el estudio
#52	AnnotatorNotes T66	C1278516; Patient participation status; Finding
R35	Before Arg1:T14 Arg2:T66	
R37	Used_for Arg1:T42 Arg2:T41	
R38	Used_for Arg1:T15 Arg2:T41	
R39	Overlap Arg1:T15 Arg2:T60	
R40	Overlap Arg1:T42 Arg2:T60	
R41	Overlap Arg1:T17 Arg2:T61	
T70	Quantifier_or_Qualifier 1036 1047	planificada
#53	AnnotatorNotes T70	C1301732; Planned; Functional Concept
R42	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T70	
R43	Overlap Arg1:T21 Arg2:T62	
R44	Overlap Arg1:T20 Arg2:T62	
T73	Quantifier_or_Qualifier 1060 1066	activo
#54	AnnotatorNotes T73	C0679217; Active State; Idea or Concept
R45	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T73	
T74	Quantifier_or_Qualifier 1093 1116	clínicamente relevantes
R46	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T74	
T75	Result_or_Value 1160 1182	<100,000 plaquetas /ml
R47	Has_Result_or_Value Arg1:T22 Arg2:T75	
R48	Has_Route_or_Mode Arg1:T25 Arg2:T63	
R49	Used_for Arg1:T25 Arg2:T24	
R50	Location_of Arg1:T43 Arg2:T28	
R51	Negation Arg1:T59 Arg2:T49	
R52	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T49	
T76	Result_or_Value 1382 1397	>180 mmHg o 120
R53	Has_Result_or_Value Arg1:T44 Arg2:T76	
R54	Causes Arg1:T31 Arg2:T16	
R55	Causes Arg1:T32 Arg2:T16	
R56	Causes Arg1:T33 Arg2:T16	
R57	Causes Arg1:T34 Arg2:T16	
T77	Observation 1524 1552	expectativa de vida limitada
#55	AnnotatorNotes T77	C1504437; Life expectancy shortened; Finding
R58	Causes Arg1:T35 Arg2:T77	
R59	Negation Arg1:T67 Arg2:T36	
T78	Observation 1661 1682	previsión de embarazo
#56	AnnotatorNotes T78	C0032992; Pregnancy, Planned; Finding (?)
R60	Before Arg1:T78 Arg2:T71	
#57	AnnotatorNotes T74	C5209294; Clinical relevance; Intellectual Product
#58	AnnotatorNotes T15	C3640054; Glycoprotein IIb/IIIa Antagonist; Chemical Viewed Functionally
#59	AnnotatorNotes T47	C0521116; Current (present time); Temporal Concept
A16	Experiencer T48 Patient
A17	Experiencer T51 Patient
A18	Experiencer T58 Patient
A19	Status T18 Future
A20	Status T71 Future
